News Detail

New Delhi, 13 June 2023: The drug price regulator has formulated guidelines to handle applications from the marketers seeking change in manufacturer for the formulations for which retail price has already been notified and product launched in the market, in future. The step has b......
View Details
Source : Pharmabiz
drug price regulator
marketers
NPPA
retail price
Voveran
Nitin Life Sciences
ESG Policy
Sovereign Pharma
Ease of Doing Business
chlorthalidone
telmisartan
Rosucor Gold
Synokem Pharmaceuticals
DPCO 2013
Related News
- NPPA asks retailers, dealers and online pharmacies to ensure compliance of Para 24 and 25 of DPCO, 2013 (11-02-2025)
- Kerala: 12 establishments caught selling fake cosmetics, including soaps and creams, with harmful chemicals (11-02-2025)
- EMA establishes regular procedure for scientific advice on certain high-risk medical devices (11-02-2025)
- Goyal urges the pharmaceutical industry to expose those engaged in sale of counterfeit products (11-02-2025)
- WHO identifies research priorities for boosting fight against antimicrobial resistance (11-02-2025)
- Supreme Court Calls on State Officials to Address Misleading Drug Advertisements (10-02-2025)
- Cases will be initiated immediately against individuals involved in sale of intoxicants and adulteration of drugs (10-02-2025)
- An index to gauge states for drug enforcement, improve drug quality (10-02-2025)
- China's health regulator defends quality of local generic drugs (10-02-2025)
- DGFT amends standard input output norms for erythromycin stearate tablets (10-02-2025)